A retrospective study evaluating association between pharmacokinetic parameters and clinical variables in haemophilia A patients to identify and treat the specific causes of poor bleeding control in recombinant factor VIII prophylaxis therapy.

Trial Profile

A retrospective study evaluating association between pharmacokinetic parameters and clinical variables in haemophilia A patients to identify and treat the specific causes of poor bleeding control in recombinant factor VIII prophylaxis therapy.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 11 Jan 2017

At a glance

  • Drugs Rurioctocog alfa (Primary)
  • Indications Haemophilia A
  • Focus Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 11 Jan 2017 New trial record
    • 06 Dec 2016 Preliminary results (n=19) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top